A Phase I Clinical Trial of Bevacizumab Injection

NCT05476341 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Rectal Cancer
Lung Cancer
Ovarian Cancer
Cervical Cancer
Glioblastoma

Interventions

DRUG: Bevacizumab injection
DRUG: Bevacizumab injection（Avastin）

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.